A Phase 2b, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken at Bedtime in Patients With Fibromyalgia
Phase of Trial: Phase II/III
Latest Information Update: 27 Dec 2016
At a glance
- Drugs Cyclobenzaprine (Primary)
- Indications Fibromyalgia
- Focus Registrational; Therapeutic Use
- Acronyms BESTFIT
- Sponsors Tonix Pharmaceuticals Inc
- 16 Nov 2016 Results of a pain responder analysis presented at the 80th American College of Rheumatology and the 51st Annual Meeting of the Association of Rheumatology and Health Professionals
- 30 Sep 2016 Results of a retrospective analysis presented at the 16th World Congress on Pain.
- 09 Jun 2016 Results of a retrospective analysis from Phase IIb part of the study published in Tonix Pharmaceuticals the Media Release.